Insilico Medicine Included in MSCI Global Small Cap Index, Recognized for Core Strengths in Capital Markets

Insilico Medicine, a clinical-stage AI-driven drug development company listed on the Hong Kong Stock Exchange under the ticker symbol 3696, announced its inclusion in the Morgan Stanley Capital International (MSCI) Global Small Cap Indexes, effective after market close on August 31st, 2026. MSCI, also known as Morgan Stanley Capital International, is one of the world’s most influential index providers, with its indexes serving as benchmarks for a wide range of institutional investors and passive funds globally. The MSCI Global Small Cap Index aims to reflect the performance of small-cap companies in developed and emerging markets, covering diverse market sectors and…